Summary & Overview
HCPCS S0169: Calcitriol, 0.25 microgram
HCPCS Level II code S0169 denotes Calcitriol, 0.25 microgram, an active vitamin D formulation used in managing conditions with impaired calcium metabolism. Nationally, this code is used to identify the specific drug product for billing and tracking drug administration or supply in outpatient and clinic settings. Accurate coding of S0169 ensures consistent claims submission for a therapy that can affect mineral balance and patient safety.
Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for calcitriol use, common sites of service where S0169 is billed, and the practical implications for billing workflows. The publication also summarizes benchmarking points and relevant policy considerations that affect coverage and claim adjudication nationally. Where input data is missing, the document notes that specific items are not available.
This briefing is written for compliance officers, practice managers, and revenue cycle professionals seeking a clear reference on the clinical meaning and billing context of HCPCS Level II code S0169 and what to expect when this code appears on service lines.
Billing Code Overview
HCPCS Level II code S0169 represents Calcitriol, 0.25 microgram, a prescription medication formulation of the active form of vitamin D. The service type is drug administration / pharmaceutical supply, and the typical site of service is outpatient clinic, physician office, or infusion/chemotherapy center where prescribed oral or injectable formulations are dispensed or administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with chronic kidney disease-associated hypocalcemia or secondary hyperparathyroidism receiving outpatient intravenous or oral vitamin D analog therapy. The medication S0169 (Calcitriol, 0.25 microgram) is supplied to a dialysis center, infusion clinic, or outpatient pharmacy for administration or patient self-administration. Clinical workflow: clinician documents the indication and formulates a dosing plan (for example, titration for hypocalcemia or suppression of parathyroid hormone), orders the medication in the electronic medical record, and coordinates supply through the outpatient pharmacy or dialysis supply vendor. Nursing or dialysis staff verify the patient identity, review current calcium and phosphorus laboratory results, administer or dispense the S0169 unit, and document lot number, dose, route, date, and time in the medical record. Routine monitoring includes serum calcium, phosphorus, and parathyroid hormone levels, with dose adjustments documented by the prescribing clinician.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work or time is required for medication preparation or patient-specific counseling beyond typical supply transaction. |